Last 12 months
Inside the activity.
0 purchase rows · 204 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 17 |
| Dec 2025 | 0 | 26 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 8 |
| Jun 2026 | 0 | 32 |
| Jul 2026 | 0 | 64 |
| Aug 2026 | 0 | 27 |
| Sep 2026 | 0 | 20 |
| Oct 2026 | 0 | 5 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 26, 2017 Filed Dec 28, 2017 22:49 UTC |
OYLER JOHNDirector · Chief Executive Officer · 10% owner
|
SaleAmerican Depositary Shares | 1,700 | $97.83 | $166,316.78 |
DisclosureSEC source: 0001179110-17-015909 · edgar.xml · nonDerivative · entry 3 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,200 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.31 to $98.15, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| December 26, 2017 Filed Dec 28, 2017 22:49 UTC |
OYLER JOHNDirector · Chief Executive Officer · 10% owner
|
SaleAmerican Depositary Shares | 8,279 | $96.68 | $800,397.99 |
DisclosureSEC source: 0001179110-17-015909 · edgar.xml · nonDerivative · entry 2 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,900 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.23 to $97.09, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| December 26, 2017 Filed Dec 28, 2017 22:49 UTC |
OYLER JOHNDirector · Chief Executive Officer · 10% owner
|
SaleAmerican Depositary Shares | 8,958 | $95.55 | $855,910.03 |
DisclosureSEC source: 0001179110-17-015909 · edgar.xml · nonDerivative · entry 1 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,179 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.22 to $96.21, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| December 22, 2017 Filed Feb 13, 2018 21:25 UTC |
Wang XiaodongDirector
|
GiftOrdinary Shares | 36,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-002002 · edgar.xml · nonDerivative · entry 1 Wang Xiaodong · CIK 0001662982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,879,311 F1 · shares: Bona fide gift of shares which is exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16b-5. F2 · balance_after: The total reported in Column 5 has been adjusted to correct an error in the total holding reflected in a Form 4 filed on June 30, 2017 and the subsequent Form 4s. Read SEC document |
| December 21, 2017 Filed Dec 22, 2017 21:43 UTC |
Huang JaneCMO, Hematology
|
Exercise / conversionShare Option (Right to Buy) · Derivative | 13,000 | $0.00 Strike: $2.27 | $0.00 |
DisclosureSEC source: 0001179110-17-015851 · edgar.xml · derivative · entry 4 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,367,500 Underlying: Ordinary Shares · 1,367,500 shares Expires 2026-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares ("ADSs") on the date of grant, as each ADS represents 13 ordinary shares. F3 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of September 2, 2016 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon certain termination events. Read SEC document |
| December 21, 2017 Filed Dec 22, 2017 21:43 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 1,000 | $98.00 | $98,000.00 |
DisclosureSEC source: 0001179110-17-015851 · edgar.xml · nonDerivative · entry 2 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| December 21, 2017 Filed Dec 22, 2017 21:43 UTC |
Huang JaneCMO, Hematology
|
Exercise / conversionAmerican Depositary Shares | 1,000 | $29.51 | $29,510.00 |
DisclosureSEC source: 0001179110-17-015851 · edgar.xml · nonDerivative · entry 1 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| December 13, 2017 Filed Dec 15, 2017 21:05 UTC |
Huang JaneCMO, Hematology
|
Exercise / conversionShare Option (Right to Buy) · Derivative | 19,500 | $0.00 Strike: $2.27 | $0.00 |
DisclosureSEC source: 0001179110-17-015428 · edgar.xml · derivative · entry 5 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,380,500 Underlying: Ordinary Shares · 1,380,500 shares Expires 2026-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares ("ADSs") on the date of grant, as each ADS represents 13 ordinary shares. F4 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of September 2, 2016 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon certain termination events. Read SEC document |
| December 13, 2017 Filed Dec 15, 2017 21:05 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 200 | $94.53 | $18,906.00 |
DisclosureSEC source: 0001179110-17-015428 · edgar.xml · nonDerivative · entry 3 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| December 13, 2017 Filed Dec 15, 2017 21:05 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 1,300 | $94.21 | $122,474.82 |
DisclosureSEC source: 0001179110-17-015428 · edgar.xml · nonDerivative · entry 2 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.50 to $94.49, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| December 13, 2017 Filed Dec 15, 2017 21:05 UTC |
Huang JaneCMO, Hematology
|
Exercise / conversionAmerican Depositary Shares | 1,500 | $29.51 | $44,265.00 |
DisclosureSEC source: 0001179110-17-015428 · edgar.xml · nonDerivative · entry 1 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| December 08, 2017 Filed Dec 8, 2017 22:57 UTC |
OYLER JOHNDirector · Chief Executive Officer · 10% owner
|
SaleAmerican Depositary Shares | 4,800 | $96.67 | $464,022.24 |
DisclosureSEC source: 0001179110-17-015165 · edgar.xml · nonDerivative · entry 13 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,137 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.21 to $96.86, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| December 08, 2017 Filed Dec 8, 2017 22:57 UTC |
OYLER JOHNDirector · Chief Executive Officer · 10% owner
|
SaleAmerican Depositary Shares | 37,208 | $95.62 | $3,557,884.77 |
DisclosureSEC source: 0001179110-17-015165 · edgar.xml · nonDerivative · entry 12 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,937 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.12 to $96.01, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| December 08, 2017 Filed Dec 8, 2017 22:57 UTC |
OYLER JOHNDirector · Chief Executive Officer · 10% owner
|
SaleAmerican Depositary Shares | 10,809 | $94.91 | $1,025,850.84 |
DisclosureSEC source: 0001179110-17-015165 · edgar.xml · nonDerivative · entry 11 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,145 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.11 to $95.10, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 22:57 UTC |
OYLER JOHNDirector · Chief Executive Officer · 10% owner
|
SaleAmerican Depositary Shares | 100 | $96.66 | $9,666.00 |
DisclosureSEC source: 0001179110-17-015165 · edgar.xml · nonDerivative · entry 10 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,954 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 22:57 UTC |
OYLER JOHNDirector · Chief Executive Officer · 10% owner
|
SaleAmerican Depositary Shares | 5,162 | $96.12 | $496,174.54 |
DisclosureSEC source: 0001179110-17-015165 · edgar.xml · nonDerivative · entry 9 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,054 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.64 to $96.60, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 22:57 UTC |
OYLER JOHNDirector · Chief Executive Officer · 10% owner
|
SaleAmerican Depositary Shares | 7,743 | $94.98 | $735,434.01 |
DisclosureSEC source: 0001179110-17-015165 · edgar.xml · nonDerivative · entry 8 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,216 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.60 to $95.58, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 22:57 UTC |
OYLER JOHNDirector · Chief Executive Officer · 10% owner
|
SaleAmerican Depositary Shares | 13,213 | $93.94 | $1,241,235.83 |
DisclosureSEC source: 0001179110-17-015165 · edgar.xml · nonDerivative · entry 7 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,959 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.60 to $94.59, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 22:57 UTC |
OYLER JOHNDirector · Chief Executive Officer · 10% owner
|
SaleAmerican Depositary Shares | 9,439 | $93.23 | $880,030.06 |
DisclosureSEC source: 0001179110-17-015165 · edgar.xml · nonDerivative · entry 6 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,172 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.60 to $93.59, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 22:57 UTC |
OYLER JOHNDirector · Chief Executive Officer · 10% owner
|
SaleAmerican Depositary Shares | 24,080 | $92.06 | $2,216,763.86 |
DisclosureSEC source: 0001179110-17-015165 · edgar.xml · nonDerivative · entry 5 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,611 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.55 to $92.53, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:57 UTC |
OYLER JOHNDirector · Chief Executive Officer · 10% owner
|
SaleAmerican Depositary Shares | 1,400 | $93.96 | $131,537.42 |
DisclosureSEC source: 0001179110-17-015165 · edgar.xml · nonDerivative · entry 4 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,691 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.25, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:57 UTC |
OYLER JOHNDirector · Chief Executive Officer · 10% owner
|
SaleAmerican Depositary Shares | 4,000 | $93.02 | $372,090.00 |
DisclosureSEC source: 0001179110-17-015165 · edgar.xml · nonDerivative · entry 3 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,091 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.80 to $93.73, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:57 UTC |
OYLER JOHNDirector · Chief Executive Officer · 10% owner
|
SaleAmerican Depositary Shares | 18,046 | $92.36 | $1,666,793.53 |
DisclosureSEC source: 0001179110-17-015165 · edgar.xml · nonDerivative · entry 2 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,091 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.80 to $92.7821, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:57 UTC |
OYLER JOHNDirector · Chief Executive Officer · 10% owner
|
SaleAmerican Depositary Shares | 8,000 | $91.48 | $731,803.20 |
DisclosureSEC source: 0001179110-17-015165 · edgar.xml · nonDerivative · entry 1 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,137 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.80 to $91.79, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| December 04, 2017 Filed Dec 5, 2017 14:15 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 1,100 | $86.00 | $94,600.00 |
DisclosureSEC source: 0001179110-17-014878 · edgar.xml · nonDerivative · entry 1 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by The Jane Edna Huang Living Trust. F3 · ownership.nature: These securities are held by The Jane Edna Huang Living Trust. Read SEC document |
| November 29, 2017 Filed Nov 29, 2017 22:33 UTC |
OYLER JOHNDirector · Chief Executive Officer · 10% owner
|
SaleAmerican Depositary Shares | 36,340 | $82.92 | $3,013,458.16 |
DisclosureSEC source: 0001179110-17-014699 · edgar.xml · nonDerivative · entry 4 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,137 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| November 28, 2017 Filed Nov 29, 2017 22:33 UTC |
OYLER JOHNDirector · Chief Executive Officer · 10% owner
|
SaleAmerican Depositary Shares | 32,985 | $85.52 | $2,820,864.01 |
DisclosureSEC source: 0001179110-17-014699 · edgar.xml · nonDerivative · entry 3 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,477 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| November 27, 2017 Filed Nov 29, 2017 22:33 UTC |
OYLER JOHNDirector · Chief Executive Officer · 10% owner
|
SaleAmerican Depositary Shares | 235 | $87.49 | $20,560.15 |
DisclosureSEC source: 0001179110-17-014699 · edgar.xml · nonDerivative · entry 2 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 332,462 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| November 27, 2017 Filed Nov 29, 2017 22:33 UTC |
OYLER JOHNDirector · Chief Executive Officer · 10% owner
|
SaleAmerican Depositary Shares | 16,346 | $86.75 | $1,418,022.04 |
DisclosureSEC source: 0001179110-17-014699 · edgar.xml · nonDerivative · entry 1 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 332,697 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.27 to $87.15, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 20, 2017 Filed Nov 20, 2017 22:14 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 1,000 | $87.00 | $87,000.00 |
DisclosureSEC source: 0001179110-17-014377 · edgar.xml · nonDerivative · entry 2 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,100 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by The Jane Edna Huang Living Trust. F3 · ownership.nature: These securities are held by The Jane Edna Huang Living Trust. Read SEC document |
| November 16, 2017 Filed Nov 20, 2017 22:14 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 600 | $85.00 | $51,000.00 |
DisclosureSEC source: 0001179110-17-014377 · edgar.xml · nonDerivative · entry 1 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,100 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by The Jane Edna Huang Living Trust. F3 · ownership.nature: These securities are held by The Jane Edna Huang Living Trust. Read SEC document |
| November 15, 2017 Filed Nov 16, 2017 01:12 UTC |
OYLER JOHNDirector · Chief Executive Officer · 10% owner
|
SaleAmerican Depositary Shares | 100 | $80.84 | $8,084.00 |
DisclosureSEC source: 0001179110-17-014171 · edgar.xml · nonDerivative · entry 9 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 349,043 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person Read SEC document |
| November 15, 2017 Filed Nov 16, 2017 01:12 UTC |
OYLER JOHNDirector · Chief Executive Officer · 10% owner
|
SaleAmerican Depositary Shares | 62,170 | $80.29 | $4,991,790.94 |
DisclosureSEC source: 0001179110-17-014171 · edgar.xml · nonDerivative · entry 8 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 349,143 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.79 to $80.77, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 15, 2017 Filed Nov 16, 2017 01:12 UTC |
OYLER JOHNDirector · Chief Executive Officer · 10% owner
|
SaleAmerican Depositary Shares | 3,798 | $79.16 | $300,632.97 |
DisclosureSEC source: 0001179110-17-014171 · edgar.xml · nonDerivative · entry 7 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 411,313 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.69 to $79.64, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 14, 2017 Filed Nov 16, 2017 01:12 UTC |
OYLER JOHNDirector · Chief Executive Officer · 10% owner
|
SaleAmerican Depositary Shares | 100 | $81.00 | $8,100.00 |
DisclosureSEC source: 0001179110-17-014171 · edgar.xml · nonDerivative · entry 6 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 415,111 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person Read SEC document |
| November 14, 2017 Filed Nov 16, 2017 01:12 UTC |
OYLER JOHNDirector · Chief Executive Officer · 10% owner
|
SaleAmerican Depositary Shares | 20,407 | $80.10 | $1,634,500.71 |
DisclosureSEC source: 0001179110-17-014171 · edgar.xml · nonDerivative · entry 5 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 415,211 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.96 to $80.84, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 14, 2017 Filed Nov 16, 2017 01:12 UTC |
OYLER JOHNDirector · Chief Executive Officer · 10% owner
|
SaleAmerican Depositary Shares | 39,328 | $79.55 | $3,128,349.69 |
DisclosureSEC source: 0001179110-17-014171 · edgar.xml · nonDerivative · entry 4 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 435,618 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.96 to $79.95, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 13, 2017 Filed Nov 16, 2017 01:12 UTC |
OYLER JOHNDirector · Chief Executive Officer · 10% owner
|
SaleAmerican Depositary Shares | 100 | $84.04 | $8,404.00 |
DisclosureSEC source: 0001179110-17-014171 · edgar.xml · nonDerivative · entry 3 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 474,946 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person Read SEC document |
| November 13, 2017 Filed Nov 16, 2017 01:12 UTC |
OYLER JOHNDirector · Chief Executive Officer · 10% owner
|
SaleAmerican Depositary Shares | 16,845 | $83.24 | $1,402,135.69 |
DisclosureSEC source: 0001179110-17-014171 · edgar.xml · nonDerivative · entry 2 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 475,046 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.03 to $84.00, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 13, 2017 Filed Nov 16, 2017 01:12 UTC |
OYLER JOHNDirector · Chief Executive Officer · 10% owner
|
SaleAmerican Depositary Shares | 8,109 | $82.67 | $670,375.90 |
DisclosureSEC source: 0001179110-17-014171 · edgar.xml · nonDerivative · entry 1 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 491,891 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.03 to $83.02, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 13, 2017 Filed Nov 16, 2017 01:11 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
SaleAmerican Depositary Shares | 1,201 | $83.31 | $100,054.23 |
DisclosureSEC source: 0001179110-17-014170 · edgar.xml · nonDerivative · entry 2 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.13 to $84.04, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 13, 2017 Filed Nov 16, 2017 01:11 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
SaleAmerican Depositary Shares | 2,400 | $82.79 | $198,692.88 |
DisclosureSEC source: 0001179110-17-014170 · edgar.xml · nonDerivative · entry 1 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,201 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.12 to $83.11, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| October 13, 2017 Filed Oct 16, 2017 21:47 UTC |
BAKER BROS. ADVISORS LPDirector · 10% owner
14159, L.P.Director · 10% owner
Baker Bros. Advisors (GP) LLCDirector · 10% owner
BAKER JULIANDirector · 10% owner
BAKER FELIXDirector · 10% owner
667, L.P.Director · 10% owner
Baker Brothers Life Sciences LPDirector · 10% owner
|
OtherAmerican Depositary Shares | 7,102 | $0.00 | $0.00 |
DisclosureSEC source: 0001638599-17-001020 · doc4_4974.xml · nonDerivative · entry 7 BAKER BROS. ADVISORS LP · CIK 0001263508 · Director · 10% owner 14159, L.P. · CIK 0001551138 · Director · 10% owner Baker Bros. Advisors (GP) LLC · CIK 0001580575 · Director · 10% owner BAKER JULIAN · CIK 0001087939 · Director · 10% owner BAKER FELIX · CIK 0001087940 · Director · 10% owner 667, L.P. · CIK 0001551139 · Director · 10% owner Baker Brothers Life Sciences LP · CIK 0001363364 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,102 F8 · ownership.direct: Reflects 7,102 ADS of the Issuer held directly by Felix J. Baker received from the in-kind pro rata distribution without consideration reported above. Read SEC document |
| October 13, 2017 Filed Oct 16, 2017 21:47 UTC |
BAKER BROS. ADVISORS LPDirector · 10% owner
14159, L.P.Director · 10% owner
Baker Bros. Advisors (GP) LLCDirector · 10% owner
BAKER JULIANDirector · 10% owner
BAKER FELIXDirector · 10% owner
667, L.P.Director · 10% owner
Baker Brothers Life Sciences LPDirector · 10% owner
|
OtherAmerican Depositary Shares | 7,102 | $0.00 | $0.00 |
DisclosureSEC source: 0001638599-17-001020 · doc4_4974.xml · nonDerivative · entry 6 BAKER BROS. ADVISORS LP · CIK 0001263508 · Director · 10% owner 14159, L.P. · CIK 0001551138 · Director · 10% owner Baker Bros. Advisors (GP) LLC · CIK 0001580575 · Director · 10% owner BAKER JULIAN · CIK 0001087939 · Director · 10% owner BAKER FELIX · CIK 0001087940 · Director · 10% owner 667, L.P. · CIK 0001551139 · Director · 10% owner Baker Brothers Life Sciences LP · CIK 0001363364 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,102 F7 · ownership.direct: Reflects 7,102 ADS of the Issuer held directly by Julian C. Baker received from the in-kind pro rata distribution without consideration reported above. Read SEC document |
| October 13, 2017 Filed Oct 16, 2017 21:47 UTC |
BAKER BROS. ADVISORS LPDirector · 10% owner
14159, L.P.Director · 10% owner
Baker Bros. Advisors (GP) LLCDirector · 10% owner
BAKER JULIANDirector · 10% owner
BAKER FELIXDirector · 10% owner
667, L.P.Director · 10% owner
Baker Brothers Life Sciences LPDirector · 10% owner
|
OtherAmerican Depositary Shares | 49,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001638599-17-001020 · doc4_4974.xml · nonDerivative · entry 5 BAKER BROS. ADVISORS LP · CIK 0001263508 · Director · 10% owner 14159, L.P. · CIK 0001551138 · Director · 10% owner Baker Bros. Advisors (GP) LLC · CIK 0001580575 · Director · 10% owner BAKER JULIAN · CIK 0001087939 · Director · 10% owner BAKER FELIX · CIK 0001087940 · Director · 10% owner 667, L.P. · CIK 0001551139 · Director · 10% owner Baker Brothers Life Sciences LP · CIK 0001363364 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F4 · ownership.nature: Represents 49,200 ADS of the Issuer, each representing 13 Ordinary Shares distributed by 14159, L.P. as part of an in-kind pro rata distribution without consideration in accordance with pecuniary interest to Julian C. Baker, Felix J. Baker and other investors in 14159, L.P. Prior to the pro rata distribution, on September 15, 2017, 639,600 Ordinary Shares directly held by 14159, L.P. were converted to 49,200 ADS. F5 · ownership.nature: As a result of their ownership interest in 14159 Capital (GP), LLC, Julian C. Baker and Felix J. Baker may be deemed to have an indirect pecuniary interest in the Issuer's Ordinary Shares reported in column 5 of Table I directly held by 14159, L.P. ("14159" and together with Life Sciences and 667, the "Funds"), a limited partnership of which the sole general partner is 14159 Capital, L.P., a limited partnership of which the sole general partner is 14159 Capital (GP), LLC, due to 14159 Capital, L.P.'s right to receive an allocation of a portion of the profits from 14159. F6 · ownership.nature: Baker Bros. Advisors LP (the "Adviser") serves as the Investment Adviser to the Funds. In connection with the services provided by the Adviser, the Adviser receives an asset-based management fee that does not confer any pecuniary interest in the securities held by the Funds. Baker Bros. Advisors (GP) LLC (the "Adviser GP") is the Adviser's sole general partner. Julian C. Baker and Felix J. Baker are principals of the Adviser GP. The Adviser has complete and unlimited discretion and authority with respect to the investment and voting power of the securities held by the Funds. The general partners of the Funds relinquished to the Adviser all discretion and authority with respect to the investment and voting power of the securities held by the Funds. Julian C. Baker, Felix J. Baker, the Adviser GP and the Adviser disclaim beneficial ownership of the securities held directly by the Funds except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that any of Julian C. Baker, Felix J. Baker, the Adviser GP or the Adviser is a beneficial owner of such securities for purposes of Section 16 or any other purpose. Read SEC document |
| September 27, 2017 Filed Oct 2, 2017 11:10 UTC |
OYLER JOHNDirector · Chief Executive Officer · 10% owner
|
GrantShare Option (Right to Buy) · Derivative | 935,000 | $0.00 Strike: $7.70 | $0.00 |
DisclosureSEC source: 0001179110-17-012803 · edgar.xml · derivative · entry 6 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 935,000 Underlying: Ordinary Shares · 935,000 shares Expires 2027-09-26 F6 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares ("ADSs") on the date of grant, as each ADS represents 13 ordinary shares. F6 · shares: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares ("ADSs") on the date of grant, as each ADS represents 13 ordinary shares. F7 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on June 30, 2018, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon a change in control or certain termination events. F6 · derivative.underlying_shares: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares ("ADSs") on the date of grant, as each ADS represents 13 ordinary shares. F6 · balance_after: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares ("ADSs") on the date of grant, as each ADS represents 13 ordinary shares. Read SEC document |
| September 27, 2017 Filed Oct 2, 2017 11:10 UTC |
OYLER JOHNDirector · Chief Executive Officer · 10% owner
|
GrantOrdinary Shares | 515,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-012803 · edgar.xml · nonDerivative · entry 1 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,745,525 F1 · security: Represents securities underlying restricted share units ("RSUs"). 1/4th of the securities will vest on each anniversary of June 30, 2017, subject to continued service. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. Read SEC document |
| September 27, 2017 Filed Oct 2, 2017 10:41 UTC |
Wang XiaodongDirector
|
GrantShare Option (Right to Buy) · Derivative | 750,000 | $0.00 Strike: $7.70 | $0.00 |
DisclosureSEC source: 0001179110-17-012802 · edgar.xml · derivative · entry 3 Wang Xiaodong · CIK 0001662982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750,000 Underlying: Ordinary Shares · 750,000 shares Expires 2027-09-26 F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares ("ADSs") on the date of grant, as each ADS represents 13 ordinary shares. F3 · shares: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares ("ADSs") on the date of grant, as each ADS represents 13 ordinary shares. F4 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on June 30, 2018, and the remaining in 36 successive equal monthly installments, subject to continued service. F3 · derivative.underlying_shares: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares ("ADSs") on the date of grant, as each ADS represents 13 ordinary shares. F3 · balance_after: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares ("ADSs") on the date of grant, as each ADS represents 13 ordinary shares. Read SEC document |
| September 27, 2017 Filed Oct 2, 2017 10:41 UTC |
Wang XiaodongDirector
|
GrantOrdinary Shares | 410,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-012802 · edgar.xml · nonDerivative · entry 1 Wang Xiaodong · CIK 0001662982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,935,393 F1 · security: Represents securities underlying restricted share units ("RSUs"). 1/4th of the securities will vest on each anniversary of June 30, 2017, subject to continued service. Read SEC document |
| August 22, 2017 Filed Aug 24, 2017 20:20 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
Tax withholdingOrdinary Shares | 28,185 | $5.39 | $151,829.78 |
DisclosureSEC source: 0001179110-17-011812 · edgar.xml · nonDerivative · entry 1 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,815 F1 · shares: Represents shares withheld to settle tax liability in connection with the vesting of a restricted share award that was previously granted on August 22, 2016. The share withholding was approved by a committee of non-employee directors in accordance with requirements of Rule 16b-3. F2 · price: Calculated based off the closing price of the Company's American Depositary Shares ("ADSs") on the date thereof. Each ADS represents 13 Ordinary Shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.